Martin Merschhemke
- Pathology and Forensic Medicine top 2%
- Cellular and Molecular Neuroscience top 5%
- Psychiatry and Mental health top 2%
- Cognitive Neuroscience top 5%
- Neurology top 5%
- Co-authors
- Louis LemieuxAfraim Salek‐HaddadiDavid R. FishJohn S. DuncanKarl FristonHeinz‐Joachim MeenckeBruce CreeNorman Putzki
- Topics
- Multiple Sclerosis Research Studies (17 papers)Epilepsy research and treatment (6 papers)Peripheral Neuropathies and Disorders (4 papers)
- Cited by
- Psychiatry and Mental healthPathology and Forensic MedicineCellular and Molecular Neuroscience
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Martin Merschhemke
31 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Pathology and Forensic Medicine 704
- Cellular and Molecular Neuroscience 623
- Psychiatry and Mental health 619
- Cognitive Neuroscience 583
- Neurology 419
Countries citing papers authored by Martin Merschhemke
This map shows the geographic impact of Martin Merschhemke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Merschhemke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Merschhemke more than expected).
Fields of papers citing papers by Martin Merschhemke
This network shows the impact of papers produced by Martin Merschhemke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Merschhemke. The network helps show where Martin Merschhemke may publish in the future.
Co-authorship network of co-authors of Martin Merschhemke
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Merschhemke. A scholar is included among the top collaborators of Martin Merschhemke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Merschhemke. Martin Merschhemke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 28 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 28 | |
| 7 | 1 | |
| 8 | 20 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trialbreakdown → | 335 |
| 12 | 0 | |
| 13 | 30 | |
| 14 | 10 | |
| 15 | 108 | |
| 16 | 216 | |
| 17 | 119 | |
| 18 | 14 | |
| 19 | 205 | |
| 20 | 92 |
About Martin Merschhemke
Martin Merschhemke is a scholar working on Pathology and Forensic Medicine, Developmental Neuroscience and Psychiatry and Mental health, having authored 33 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (17 papers), Epilepsy research and treatment (6 papers) and Peripheral Neuropathies and Disorders (4 papers). The work is most often cited by research in Psychiatry and Mental health (619 citations), Pathology and Forensic Medicine (704 citations) and Cellular and Molecular Neuroscience (623 citations). Martin Merschhemke has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Louis Lemieux, Afraim Salek‐Haddadi, David R. Fish, John S. Duncan, Karl Friston, Heinz‐Joachim Meencke, Bruce Cree, Norman Putzki, Benjamin Greenberg and Dieter A. Häring. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.